JJ
Johnson & Johnson Innovative Medicine at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Johnson & Johnson Innovative Medicine takes part in 2 sessions at BioTechX Europe 2026 in Basel. Its sessions centre on AI in clinical trials. Topics include predicting which patients are likely to drop out of a trial so teams can keep them enrolled, and, with SAS, turning long-standing clinical know-how into AI agents that coordinate R&D work.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
JJ Johnson & Johnson Innovative Medicine | |
Pharmaceutical business of Johnson & Johnson, formerly Janssen. | Talk Wed Oct 7 12:05 Orchestrating the Future of Clinical R&D: From Long-established Expertise to AI‑Driven Expert Agents How specialist AI assistants for data handling, statistics and reporting could reshape clinical research work, with human experts directing them. |
Instantly find 20 buyers from Johnson & Johnson Innovative Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction